Increasingly, cataract patients expect to be able to maintain their active lifestyle into older age, thus they require an intraocular lens (IOL) solution that enables them to perform most daily activities without visual aids. The At Lisa tri family from ZEISS is a trifocal technology that offers patients spectacle independence and is supported by a wealth of clinical evidence.
Since its launch, the ZEISS At Lisa tri family of IOLs has accumulated an extensive collection of clinical evidence attesting to its robust visual and refractive performance as well as predictability.
With over 75 peer-reviewed publications by 60 different authors detailing the results of over 9,000 eyes from 4,500 implanted patients, the ZEISS At Lisa tri offers surgeons an IOL that consistently delivers excellent results in terms of visual quality and patient satisfaction.
Contact: ZEISS Surgical Account Manager
